<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Endovascular thrombectomy and intra‐arterial interventions for acute ischaemic stroke - Roaldsen, MB - 2021 | Cochrane Library</title> <meta content="Endovascular thrombectomy and intra‐arterial interventions for acute ischaemic stroke - Roaldsen, MB - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007574.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Endovascular thrombectomy and intra‐arterial interventions for acute ischaemic stroke - Roaldsen, MB - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007574.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007574.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Endovascular thrombectomy and intra‐arterial interventions for acute ischaemic stroke" name="citation_title"/> <meta content="Melinda B Roaldsen" name="citation_author"/> <meta content="melinda.b.roaldsen@uit.no" name="citation_author_email"/> <meta content="Mirza Jusufovic" name="citation_author"/> <meta content="Oslo University Hospital" name="citation_author_institution"/> <meta content="Eivind Berge&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="Oslo University Hospital" name="citation_author_institution"/> <meta content="Haakon Lindekleiv" name="citation_author"/> <meta content="University Hospital of North Norway" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD007574.pub3" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/06/14" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007574.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007574.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007574.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Bias; Cause of Death; Fibrinolytic Agents [*administration &amp; dosage]; Infarction, Middle Cerebral Artery [therapy]; Intracranial Hemorrhages [epidemiology, etiology]; Ischemic Stroke [drug therapy, *therapy]; Mechanical Thrombolysis [*methods]; Randomized Controlled Trials as Topic; Thrombolytic Therapy [*methods]; Urokinase-Type Plasminogen Activator [administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007574.pub3&amp;doi=10.1002/14651858.CD007574.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="uQyIsxpV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007574\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007574\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ko","ms","ja","hr","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007574.pub3",title:"Endovascular thrombectomy and intra\\u2010arterial interventions for acute ischaemic stroke",firstPublishedDate:"Jun 14, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Stroke Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007574.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007574.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007574.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007574.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007574.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007574.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007574.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007574.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007574.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007574.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6105 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007574.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/full#CD007574-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/full#CD007574-sec-0087"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/full#CD007574-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/full#CD007574-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/full#CD007574-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/full#CD007574-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/full#CD007574-sec-0041"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/full#CD007574-sec-0081"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/appendices#CD007574-sec-0092"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/table_n/CD007574StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/table_n/CD007574StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Endovascular thrombectomy and intra‐arterial interventions for acute ischaemic stroke</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/information#CD007574-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Melinda B Roaldsen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/information#CD007574-cr-0005">Mirza Jusufovic</a></li> <li class="author custom-tooltip" title="Deceased"><a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/information#CD007574-cr-0006">Eivind Berge</a><sup>a</sup></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007574.pub3/information#CD007574-cr-0007">Haakon Lindekleiv</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/information/en#CD007574-sec-0101">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 14 June 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007574.pub3">https://doi.org/10.1002/14651858.CD007574.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007574-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007574-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007574-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007574-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007574-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD007574-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007574-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007574-abs-0001" lang="en"> <section id="CD007574-sec-0001"> <h3 class="title" id="CD007574-sec-0001">Background</h3> <p>Most disabling strokes are due to a blockage of a large artery in the brain by a blood clot. Prompt removal of the clot with intra‐arterial thrombolytic drugs or mechanical devices, or both, can restore blood flow before major brain damage has occurred, leading to improved recovery. However, these so‐called endovascular interventions can cause bleeding in the brain. This is a review of randomised controlled trials of endovascular thrombectomy or intra‐arterial thrombolysis, or both, for acute ischaemic stroke. </p> </section> <section id="CD007574-sec-0002"> <h3 class="title" id="CD007574-sec-0002">Objectives</h3> <p>To assess whether endovascular thrombectomy or intra‐arterial interventions, or both, plus medical treatment are superior to medical treatment alone in people with acute ischaemic stroke. </p> </section> <section id="CD007574-sec-0003"> <h3 class="title" id="CD007574-sec-0003">Search methods</h3> <p>We searched the Trials Registers of the Cochrane Stroke Group and Cochrane Vascular Group (last searched 1 September 2020), CENTRAL (the Cochrane Library, 1 September 2020), MEDLINE (May 2010 to 1 September 2020), and Embase (May 2010 to 1 September 2020). We also searched trials registers, screened reference lists, and contacted researchers. </p> </section> <section id="CD007574-sec-0004"> <h3 class="title" id="CD007574-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) of any endovascular intervention plus medical treatment compared with medical treatment alone in people with definite ischaemic stroke. </p> </section> <section id="CD007574-sec-0005"> <h3 class="title" id="CD007574-sec-0005">Data collection and analysis</h3> <p>Two review authors (MBR and MJ) applied the inclusion criteria, extracted data, and assessed trial quality. Two review authors (MBR and HL) assessed risk of bias, and the certainty of the evidence using GRADE. We obtained both published and unpublished data if available. Our primary outcome was favourable functional outcome at the end of the scheduled follow‐up period, defined as a modified Rankin Scale score of 0 to 2. Eighteen trials (i.e. all but one included trial) reported their outcome at 90 days. Secondary outcomes were death from all causes at in the acute phase and by the end of follow‐up, symptomatic intracranial haemorrhage in the acute phase and by the end of follow‐up, neurological status at the end of follow‐up, and degree of recanalisation. </p> </section> <section id="CD007574-sec-0006"> <h3 class="title" id="CD007574-sec-0006">Main results</h3> <p>We included 19 studies with a total of 3793 participants. The majority of participants had large artery occlusion in the anterior circulation, and were treated within six hours of symptom onset with endovascular thrombectomy. Treatment increased the chance of achieving a good functional outcome, defined as a modified Rankin Scale score of 0 to 2: risk ratio (RR) 1.50 (95% confidence interval (CI) 1.37 to 1.63; 3715 participants, 18 RCTs; high‐certainty evidence). Treatment also reduced the risk of death at end of follow‐up: RR 0.85 (95% CI 0.75 to 0.97; 3793 participants, 19 RCTs; high‐certainty evidence) without increasing the risk of symptomatic intracranial haemorrhage in the acute phase: RR 1.46 (95% CI 0.91 to 2.36; 1559 participants, 6 RCTs; high‐certainty evidence) or by end of follow‐up: RR 1.05 (95% CI 0.72 to 1.52; 1752 participants, 10 RCTs; high‐certainty evidence); however, the wide confidence intervals preclude any firm conclusion. Neurological recovery to National Institutes of Health Stroke Scale (NIHSS) score 0 to 1 and degree of recanalisation rates were better in the treatment group: RR 2.03 (95% CI 1.21 to 3.40; 334 participants, 3 RCTs; moderate‐certainty evidence) and RR 8.25 (95% CI 1.63 to 41.90; 198 participants, 2 RCTs; moderate‐certainty evidence), respectively. </p> </section> <section id="CD007574-sec-0007"> <h3 class="title" id="CD007574-sec-0007">Authors' conclusions</h3> <p>In individuals with acute ischaemic stroke due to large artery occlusion in the anterior circulation, endovascular thrombectomy can increase the chance of survival with a good functional outcome without increasing the risk of intracerebral haemorrhage or death. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007574-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007574-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007574-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007574-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007574-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD007574-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD007574-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD007574-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007574-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007574-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD007574-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007574-abs-0002" lang="en"> <h3>Endovascular thrombectomy and intra‐arterial interventions for acute ischaemic stroke</h3> <p><b>Review question</b> </p> <p>This review addressed whether endovascular thrombectomy (removal of a blood clot in a blood vessel using a mechanical device) or intra‐arterial thrombolysis (injecting clot‐dissolving drugs directly into the clot), or both, provide better outcomes than standard treatment alone in stroke caused by a blocked blood vessel. </p> <p><b>Background</b> </p> <p>The majority of disabling strokes are due to a blockage of a large blood vessel by a blood clot in the brain. Such strokes lead to brain tissue damage because of oxygen deprivation. An ischaemic stroke is a stroke where the restriction of blood flow causes damage and death to the surrounding tissue due to oxygen shortage. For these patients, the most intuitive means of treatment is removal of the blockage by either injecting clot‐dissolving drugs directly into the clot or removal of the blood clot using a mechanical device, or both. Prompt treatment can restore blood flow before major brain damage has occurred, leading to a good recovery. However, these treatments can also cause bleeding in the brain, which can result in poorer outcomes. We searched for randomised controlled trials (studies in which participants are assigned to one of two or more treatment groups using a random method) of both endovascular mechanical thrombectomy and intra‐arterial thrombolysis to establish whether they are safe and effective treatments for stroke caused by a blocked blood vessel. </p> <p><b>Search date</b> </p> <p>1 September 2020</p> <p><b>Study characteristics</b> </p> <p>Randomised controlled trials of endovascular thrombectomy or intra‐arterial thrombolysis, or both, plus routine medical treatment compared with routine medical treatment alone in people with a definite acute ischaemic stroke. </p> <p><b>Study funding sources</b> </p> <p>No funding sources.</p> <p><b>Key results</b> </p> <p>We found 19 trials involving a total of 3793 participants. Treatment with endovascular thrombectomy can improve patients' chance of survival with the ability to function well without increasing the risk of bleeding in the brain or death. It is still unclear what the optimal time window is within which treatment is beneficial and whether treatment is effective in the posterior (supplying the rear part of the brain) circulation. There is also a need to study whether a strategy of primary endovascular thrombectomy or intra‐arterial thrombolysis, or both, is superior to a strategy where intravenous (injected into the vein) clot‐dissolving treatment is provided first in a local centre followed by transfer of selected patients to hospitals able to perform mechanical thrombectomy or intra‐arterial thrombolysis, or both. </p> <p><b>Certainty of the evidence</b> </p> <p>We judged the available trials to be at low or unclear risk of bias, and so overall the evidence is reported to be of high certainty. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007574-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007574-sec-0087"></div> <h3 class="title" id="CD007574-sec-0088">Implications for practice</h3> <section id="CD007574-sec-0088"> <p>We found high‐certainty evidence that endovascular thrombectomy improves functional and neurological outcomes without increasing haemorrhage or death. The benefit was seen with/without intravenous thrombolysis and was unrelated to age, sex, and time to intervention (although most participants were treated within six hours of symptom onset). Benefits were greater with more severe stroke. </p> </section> <h3 class="title" id="CD007574-sec-0089">Implications for research</h3> <section id="CD007574-sec-0089"> <p>Very few trials included individuals with posterior circulation infarcts, but trials are underway that will try to answer whether similar benefits can be achieved in such patients (<a href="./references#CD007574-bbs2-0028" title="NCT01717755.Basilar Artery International Cooperation Study (BASICS). clinicaltrials.gov/ct2/show/NCT01717755 (first received 30 October 2012). ">NCT01717755</a>). New trials are also needed to confirm the maximum time window for endovascular thrombectomy to be effective, and how advanced imaging techniques should be used to identify patients who might benefit from treatment in the late hours after stroke onset. We also expect that with time and research development of endovascular thrombectomy, new techniques will emerge. </p> <p>On a population level, there is a need to investigate whether a strategy of primary endovascular thrombectomy is superior to a strategy with primary intravenous thrombolytic treatment in a local centre followed by transfer of eligible patients to an interventional centre. If such a strategy is superior, what is the maximum time delay for primary endovascular thrombectomy intervention to be superior to intravenous thrombolysis followed by intervention? </p> <p>Furthermore, endovascular thrombectomy is performed by professionals from many disciplines, including neuroradiologists, general interventional radiologists, neurologists, neurosurgeons, and cardiologists. It is unknown whether the effect of treatment depends on the professional background of the interventionalist or the annual number of procedures. This information is important for determining whether endovascular thrombectomy could be provided by interventional cardiologists or radiologists in smaller hospitals. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007574-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007574-sec-0008"></div> <div class="table" id="CD007574-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Endovascular thrombectomy interventions compared to standard therapy for acute ischaemic stroke</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Endovascular thrombectomy interventions compared to standard therapy for acute ischaemic stroke</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute ischaemic stroke<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> endovascular thrombectomy or intra‐arterial interventions, or both<br/><b>Comparison:</b> standard therapy </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with routine medical treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with endovascular thrombectomy interventions</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favourable functional outcome at the end of follow‐up (primary outcome: mRS score 0 to 2) </p> <p>Follow‐up: 90 days<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>290 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>435 per 1000<br/>(397 to 475) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.50<br/>(1.37 to 1.63) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3715<br/>(18 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death from all causes at the end of follow‐up</p> <p>Follow‐up: 90 days<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>207 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>176 per 1000<br/>(153 to 203) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.85<br/>(0.75 to 0.97) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3793<br/>(19 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptomatic intracranial haemorrhage at the</p> <p>end of follow‐up (NINDS)</p> <p>Follow‐up: 90 days<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>58 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>58 per 1000<br/>(37 to 88) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.05<br/>(0.72 to 1.52) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1752<br/>(10 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neurological status at the end of follow‐up (NIHSS)</p> <p>Follow‐up: 90 days<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>123 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>250 per 1000<br/>(149 to 418) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.03<br/>(1.21 to 3.40) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>334<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Degree of recanalisation (TIMI grade)</p> <p>Follow‐up: End of endovascular procedure</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>129 per 1000<br/>(25 to 655) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 8.25<br/>(1.63 to 41.90) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>198<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>mRS: </b> modified Rankin Scale; <b>NINDS: </b> National Institute of Neurological Disorders and Stroke; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>All trials had 90 days follow‐up with the exception of one trial of 16 patients (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>). </p> <p><sup>b</sup>Only one of these RCTs could be blinded for surgeons or participants due to the nature of the intervention. </p> <p><sup>c</sup>Downgraded for imprecision (wide confidence interval) </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007574-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007574-sec-0009"></div> <p>Acute ischaemic stroke is a major cause of death and disability worldwide (<a href="./references#CD007574-bbs2-0046" title="WarlowC , SudlowC , DennisM , SandercockP .Stroke. Lancet2003;362:1211-24.">Warlow 2003</a>). The usual mechanism is a thrombotic occlusion of a cerebral artery; intravenous thrombolytic treatment with recombinant tissue plasminogen activator (rt‐PA) within 4.5 hours of stroke onset reduces disability (<a href="./references#CD007574-bbs2-0045" title="WardlawJ , MurrayV , BergeE , delZoppoG .Thrombolysis for acute ischaemic stroke. Cochrane Database of Systematic Reviews2009, Issue 3. Art. No: CD000213. [DOI: 10.1002/14651858.CD000213]">Wardlaw 2009</a>), and is the routine recanalisation treatment. The rapidly developing field of interventional radiology currently offers a variety of alternative approaches to recanalisation in acute ischaemic stroke. This is a review of randomised controlled trials of endovascular thrombectomy and intra‐arterial interventions for acute ischaemic stroke (<a href="./references#CD007574-bbs2-0048" title="O'RourkeK , BergeE , WalshCD , KellyPJ .Percutaneous vascular interventions for acute ischaemic stroke. Cochrane Database of Systematic Reviews2010, Issue 10. Art. No: CD007574. [DOI: 10.1002/14651858.CD007574.pub2]">O'Rourke 2010</a>). </p> <section id="CD007574-sec-0010"> <h3 class="title" id="CD007574-sec-0010">Description of the condition</h3> <p>An ischaemic stroke is caused by the disruption of blood flow due to a blood clot, which results in brain tissue damage and loss of function. Ischaemic stroke constitutes approximately 80% to 85% of all strokes. </p> </section> <section id="CD007574-sec-0011"> <h3 class="title" id="CD007574-sec-0011">Description of the intervention</h3> <p>Endovascular thrombectomy and intra‐arterial techniques are recanalisation therapies where the blood clot is either removed using a mechanical device, most often stent retrievers; or thrombolytic medication is injected by intra‐arterial means directly to the blood clot. We included all the following techniques. </p> <p> <ul id="CD007574-list-0001"> <li> <p>Angiojet aspiration</p> </li> <li> <p>Laser recanalisation</p> </li> <li> <p>Thromboaspiration (retrieval devices)</p> </li> <li> <p>Angioplasty</p> </li> <li> <p>Mechanical fragmentation of the thrombus</p> </li> <li> <p>Implantation of stents</p> </li> <li> <p>Intra‐arterial thrombolysis</p> </li> <li> <p>Intra‐arterial sonothrombolysis</p> </li> </ul> </p> </section> <section id="CD007574-sec-0012"> <h3 class="title" id="CD007574-sec-0012">How the intervention might work</h3> <p>The goal of endovascular thrombectomy and intra‐arterial interventions is to remove or dissolve the blood clot causing the stroke symptoms, either by using a mechanical device or, in some cases, by injecting thrombolytic drugs, such as urokinase or alteplase, directly to the embolus, or by a combination of both techniques. If recanalisation is achieved, the patient's affected brain tissue can recover, and if done in time and without complications, the patient's functional outcome can be significantly improved. </p> </section> <section id="CD007574-sec-0013"> <h3 class="title" id="CD007574-sec-0013">Why it is important to do this review</h3> <p>An up‐to‐date review on endovascular thrombectomy and intra‐arterial thrombolysis for acute ischaemic stroke is highly warranted and will clarify the efficacy and safety of these relatively new acute treatment modalities for acute ischaemic stroke, which is in rapid development and gaining considerable clinical significance in acute stroke care. Several new publications in this field are included in this updated and highly relevant review. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007574-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007574-sec-0014"></div> <p>To assess whether endovascular thrombectomy or intra‐arterial interventions, or both, plus medical treatment are superior to medical treatment alone in people with acute ischaemic stroke. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007574-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007574-sec-0015"></div> <section id="CD007574-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007574-sec-0017"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) comparing endovascular thrombectomy and intra‐arterial interventions plus medical treatment to medical treatment alone in people with definite acute ischaemic stroke. We excluded cluster randomised trials. </p> </section> <section id="CD007574-sec-0018"> <h4 class="title">Types of participants</h4> <p>People with a definite acute ischaemic stroke (a computed tomography (CT) or magnetic resonance imaging (MRI) must have excluded cerebral haemorrhage). </p> </section> <section id="CD007574-sec-0019"> <h4 class="title">Types of interventions</h4> <p>All endovascular thrombectomy and intra‐arterial techniques aimed at revascularisation in acute ischaemic stroke, including but not limited to: </p> <p> <ul id="CD007574-list-0002"> <li> <p>angiojet aspiration;</p> </li> <li> <p>laser recanalisation;</p> </li> <li> <p>thromboaspiration (retrieval devices);</p> </li> <li> <p>angioplasty;</p> </li> <li> <p>mechanical fragmentation of the thrombus;</p> </li> <li> <p>implantation of stents;</p> </li> <li> <p>intra‐arterial thrombolysis;</p> </li> <li> <p>intra‐arterial sonothrombolysis.</p> </li> </ul> </p> <p>All types of medical treatment could be given in addition to the endovascular thrombectomy and intra‐arterial techniques. </p> <section id="CD007574-sec-0020"> <h5 class="title">Type of comparison therapy</h5> <p>The comparison therapy was routine medical treatment. Intravenous thrombolytic treatment was permissible only when the same intravenous thrombolytic treatment was also given to the intervention group. </p> </section> </section> <section id="CD007574-sec-0021"> <h4 class="title">Types of outcome measures</h4> <section id="CD007574-sec-0022"> <h5 class="title">Primary outcomes</h5> <p>Favourable functional outcome at the end of the scheduled follow‐up period defined as a modified Rankin Scale (mRS) score of 0 to 2. Given that some prefer a definition of 'favourable outcome' as a score of 0 to 1 (<a href="./references#CD007574-bbs2-0041" title="The NINDS rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine1995;333:1581-7.">NINDS 1995</a>), we also sought data on the number of participants in each individual mRS category. If the mRS score was not reported, we used the trial's definition of functional outcome. Eighteen of the included trials (i.e. all but one trial: <a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>) reported their outcome at 90 days. </p> </section> <section id="CD007574-sec-0023"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD007574-list-0003"> <li> <p>Death from all causes, both:</p> <ul id="CD007574-list-0004"> <li> <p>during the acute phase, i.e. first seven to 10 days; and</p> </li> <li> <p>at the end of scheduled follow‐up.</p> </li> </ul> </li> <li> <p>Symptomatic intracranial haemorrhage within the acute phase (non‐fatal or fatal) and at the end of follow‐up. We defined symptomatic intracranial haemorrhage according to both the National Institute of Neurological Disorders and Stroke (NINDS) study (<a href="./references#CD007574-bbs2-0041" title="The NINDS rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine1995;333:1581-7.">NINDS 1995</a>), and the European Cooperative Acute Stroke Study (ECASS) criteria (<a href="./references#CD007574-bbs2-0035" title="HackeW , KasteM , FieschiC , ToniD , LesaffreE , vonKummerR , et al.Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA1995;274:1017-25.">Hacke 1995</a>). When symptomatic intracranial haemorrhage was not reported according to these criteria, we used the trial's definition. </p> </li> <li> <p>Neurological status at the end of follow‐up. We defined favourable neurological outcome as National Institutes of Health Stroke Scale (NIHSS) score 0 to 1. </p> </li> <li> <p>Degree of recanalisation, according to <a href="./references#CD007574-bbs2-0036" title="HigashidaR , FurlanA .Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke2003;34:e109-37.">Higashida 2003</a>, and using the Thrombolysis In Myocardial Infarction (TIMI) grade (<a href="./references#CD007574-bbs2-0039" title="KhatriP , NeffJ , BroderickJ , KhouryJC , CarrozzellaJ , TomsickT .Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke2005;36:2400-3.">Khatri 2005</a>) or the Thrombolysis In Cerebral Infarction (TICI) grade. </p> </li> <li> <p>Major extracranial haemorrhage in the acute phase.</p> </li> </ul> </p> </section> </section> </section> <section id="CD007574-sec-0024"> <h3 class="title">Search methods for identification of studies</h3> <p>See the methods for the Cochrane Stroke Group <a href="http://www.dcn.ed.ac.uk/csrg/entity/searchmethods.pdf" target="_blank">Specialised Register</a>. We searched for trials in all languages and arranged for translation of trial reports where necessary. </p> <section id="CD007574-sec-0025"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Stroke Group Specialised Register (1 September 2020) and the Trials Register of Cochrane Vascular Group (last searched 1 September 2020). In addition, we updated the searches in the following electronic databases. (We adapted the MEDLINE search strategy for the other databases.) </p> <p> <ul id="CD007574-list-0005"> <li> <p>MEDLINE Ovid (from May 2010 to 1 September 2020) (<a href="./appendices#CD007574-sec-0093">Appendix 1</a>). </p> </li> <li> <p>Embase Ovid (from May 2010 to 1 September 2020) (<a href="./appendices#CD007574-sec-0094">Appendix 2</a>). </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2020, Issue 8) in the Cochrane Library (searched 1 September 2020). (<a href="./appendices#CD007574-sec-0095">Appendix 3</a>) </p> </li> <li> <p>Science Citation Index (from 1980 to 1 September 2020). (<a href="./appendices#CD007574-sec-0096">Appendix 4</a>) </p> </li> </ul> </p> <p>We also searched the following ongoing trials registers (last searched 1 September 2020). </p> <p> <ul id="CD007574-list-0006"> <li> <p>Stroke Trials Registry (<a href="http://www.strokecenter.org/trials" target="_blank">www.strokecenter.org/trials</a>). </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>). (<a href="./appendices#CD007574-sec-0097">Appendix 5</a>) </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/en" target="_blank">www.who.int/ictrp/en</a>). </p> </li> </ul> </p> </section> <section id="CD007574-sec-0026"> <h4 class="title">Searching other resources</h4> <p>In an attempt to identify further published, unpublished, ongoing or planned trials, we screened reference lists of relevant trials and contacted professional organisations in neuroradiology and interventional radiology, and authors and researchers active in the field. </p> </section> </section> <section id="CD007574-sec-0027"> <h3 class="title" id="CD007574-sec-0027">Data collection and analysis</h3> <section id="CD007574-sec-0028"> <h4 class="title">Selection of studies</h4> <p>Randomised controlled trials comparing endovascular thrombectomy and intra‐arterial interventions plus medical treatment versus medical treatment alone in people with acute ischaemic stroke. Two review authors (MBR and MJ) screened the titles and abstracts of references identified by the searches. We obtained full‐paper copies of those trial reports which appeared to be eligible for inclusion based on the title and abstract. Two review authors (MBR and MJ) then assessed these for inclusion in the review. Any disagreements between the authors were resolved by discussion, with input from a third review author (HL) if needed. When a trial was excluded, we kept a record of both the report and the reason for exclusion. </p> </section> <section id="CD007574-sec-0029"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (MBR and MJ) independently extracted data from the report of each eligible trial on a specially designed data extraction form. The review authors were not blinded to journal or institution. Any disagreements between the authors were resolved by discussion, with input from a third review author (HL) if needed. We extracted the following information from each report. </p> <p> <ul id="CD007574-list-0007"> <li> <p>Diagnostic criteria used for acute ischaemic stroke, including whether magnetic resonance imaging (MRI) diffusion/perfusion mismatch, computed tomography (CT) angiography, or CT perfusion were used to identify eligible patients. </p> </li> <li> <p>Time interval from onset to randomisation.</p> </li> <li> <p>Time of groin puncture or initiation of intra‐arterial treatment.</p> </li> <li> <p>Numbers of participants in each treatment group with outcome events.</p> </li> <li> <p>Modality of endovascular thrombectomy or intra‐arterial intervention used.</p> </li> <li> <p>Precise form of comparison therapy used.</p> </li> <li> <p>Data on subgroups (NIHSS score, age, time to treatment, early ischaemic changes on CT according to the Alberta Stroke Program Early CT Score (ASPECTS), use of intravenous thrombolytic medication, and sex). </p> </li> </ul> </p> <p>One review author (MBR) entered the data into Review Manager 5 software (<a href="./references#CD007574-bbs2-0043" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan).Version 5.4. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2020.">Review Manager 2020</a>). These data were checked by another review author (HL) against the hard copy data extraction forms to correct and clarify data entry errors. When any relevant data were missing from the available publications, we contacted the principal investigators or industrial sponsors concerned. </p> </section> <section id="CD007574-sec-0030"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (MBR and HL) performed risk of bias assessment of all the included studies using Cochrane's risk of bias tool. </p> <section id="CD007574-sec-0031"> <h5 class="title">Quality assessment</h5> <p>Two review authors (MBR and HL) independently performed quality assessment of reports of eligible trials, resolving any disagreements by discussion. We used the following criteria to assess the quality of reports of eligible trials, according to Section 8.5 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007574-bbs2-0037" title="HigginsJPT , Green S editor(s).Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated March 2011). Cochrane, 2011. Available from www.handbook.cochrane.org.">Higgins 2011</a>): </p> <p> <ul id="CD007574-list-0008"> <li> <p>adequate sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>blinding: in trials of endovascular thrombectomy it is not possible to blind either the participants or those administering the interventions. However, outcome assessors can be blinded. We defined blinding as 'yes', 'no', or 'unclear' as it pertained to blinding of outcome assessors; </p> </li> <li> <p>incomplete outcome data addressed: we considered intention‐to‐treat analysis (ITT) adequate when: </p> <ul id="CD007574-list-0009"> <li> <p>participants were analysed in the groups to which they had been randomised irrespective of the treatment they received; and </p> </li> <li> <p>when the numbers of participants lost to follow‐up and the associated reasons were reported. </p> </li> </ul> </li> <li> <p>free of selective reporting;</p> </li> <li> <p>free of other bias.</p> </li> </ul> </p> <p>We used the above criteria to construct a risk of bias table for each eligible trial, as outlined in Section 8.6 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007574-bbs2-0037" title="HigginsJPT , Green S editor(s).Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated March 2011). Cochrane, 2011. Available from www.handbook.cochrane.org.">Higgins 2011</a>). </p> </section> </section> <section id="CD007574-sec-0032"> <h4 class="title">Measures of treatment effect</h4> <p>We expressed the treatment effects of dichotomous outcomes as risk ratios with 95% confidence intervals (CI). We did not plan to include continuous outcomes. </p> </section> <section id="CD007574-sec-0033"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the participant with acute ischaemic stroke. We excluded crossover trials; due to the nature of the disease and intervention, crossover trials are not possible. </p> </section> <section id="CD007574-sec-0034"> <h4 class="title">Dealing with missing data</h4> <p>We contacted study authors for missing data. Where possible, ITT analysis was applied. In reporting adverse events, we assumed the 'worst case' to avoid under‐reporting. </p> </section> <section id="CD007574-sec-0035"> <h4 class="title">Assessment of heterogeneity</h4> <p>We identified and measured statistical and clinical heterogeneity as recommended in Section 10.10.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007574-bbs2-0038" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s).Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Higgins 2021</a>). We estimated heterogeneity between trials' results using the I<sup>2</sup> statistic (<a href="./references#CD007574-bbs2-0038" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s).Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Higgins 2021</a>). </p> <p>We defined thresholds for interpreting heterogeneity (I<sup>2</sup>) as follows: </p> <p> <ul id="CD007574-list-0010"> <li> <p>0% to 30%: no heterogeneity;</p> </li> <li> <p>30% to 50%: moderate heterogeneity;</p> </li> <li> <p>50% to 80%: substantial heterogeneity;</p> </li> <li> <p>80% to 100%: considerable heterogeneity.</p> </li> </ul> </p> <p>The evaluation of heterogeneity was not based on I<sup>2</sup> alone, as the importance of consistency depends on several factors, but rather included an overall evaluation of the data. </p> </section> <section id="CD007574-sec-0036"> <h4 class="title">Assessment of reporting biases</h4> <p>We undertook extensive literature searching without restrictions on publication date or language in order to limit reporting bias. We used study protocols and trial registrations to assess studies for selective reporting. </p> </section> <section id="CD007574-sec-0037"> <h4 class="title">Data synthesis</h4> <p>We analysed the data using Review Manager 5 software (<a href="./references#CD007574-bbs2-0043" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan).Version 5.4. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2020.">Review Manager 2020</a>). Two review authors (MBR and HL) conducted the data analysis. The appropriate statistical analysis was a binary logistic regression. We selected the Mantel‐Haenszel method. </p> <p>We derived risk ratios and 95% CI for each study. We combined the results of the included studies for each outcome where appropriate. We used a fixed‐effect model for pooled data and considered not pooling data if we encountered considerable heterogeneity (I<sup>2</sup> value of 80% or more) across studies. We performed subgroup analyses using the methodology described by Deeks and colleagues (<a href="./references#CD007574-bbs2-0033" title="DeeksJJ , AltmanDG , BradburnMJ .Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: EggerM , Davey SmithG , AltmanDG , editors(s). Systematic Reviews in Health Care: Meta-analysis in Context. 2nd edition. London: BMJ Publication Group, 2001.">Deeks 2001</a>), as recommended in Section 10.11.3 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007574-bbs2-0038" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s).Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Higgins 2021</a>). </p> </section> <section id="CD007574-sec-0038"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We carried out subgroup analyses and investigation of heterogeneity (via meta‐regression) a priori on the following characteristics. </p> <p> <ul id="CD007574-list-0011"> <li> <p>Age</p> </li> <li> <p>Sex</p> </li> <li> <p>Stroke severity</p> </li> <li> <p>Early ischaemic changes on CT according ASPECTS</p> </li> <li> <p>Mean time to groin puncture or initiation of intra‐arterial treatment</p> </li> <li> <p>Intravenous thrombolytic medication</p> </li> <li> <p>Intra‐arterial intervention</p> </li> <li> <p>Localisation of cerebral artery occlusion</p> </li> <li> <p>Localisation of occlusion</p> </li> </ul> </p> <p>After reviewing the articles, we amended the subgroups to include:</p> <p> <ul id="CD007574-list-0012"> <li> <p>intra‐arterial treatment with and without mechanical thrombectomy;</p> </li> <li> <p>penumbra imaging in selecting patients to treatment.</p> </li> </ul> </p> <p>We defined subgroups by age (younger and older participants, using trial definition); sex; stroke severity (according to the NIHSS score, using each trial's cutoff for severe stroke); presence of large infarction on CT (according to ASPECTS, using each trial's cutoff for large infarction), and use of intravenous thrombolytic medication. We compared trials where the mean or median time between stroke onset and initiation of intra‐arterial treatment was shorter (&lt; 250 minutes), medium (250 to 300 minutes), or longer (&gt; 300 minutes). We compared trials that included patients with proximal occlusion only and trials of patients with both proximal and non‐proximal occlusion. We compared trials where a majority of participants were treated with no mechanical device; trials where a majority of participants were treated with first‐generation mechanical devices (i.e. Merci and Penumbra systems); and trials where a majority of participants were treated with stent retrievers. We compared trials that included intra‐arterial treatments without mechanical thrombectomy, trials that included both intra‐arterial treatments with and without mechanical thrombectomy, and trials that included patients treated with mechanical thrombectomy alone. We also compared trials that used and did not use penumbra imaging for selecting patients to treatment. </p> </section> <section id="CD007574-sec-0039"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted sensitivity analysis to compare trials included in the previous version of the review and trials identified in the current review. We also compared trials that included all planned participants versus trials that were stopped early. The sensitivity analysis only examined the primary outcome (mRS 0 to 2, or mRS 0 to 1 if data were not available for mRS 0 to 2). </p> <p>We conducted a sensitivity analysis by using the random‐effects meta analytic estimate on the primary outcome. </p> </section> <section id="CD007574-sec-0040"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We used GRADE when creating the summary of findings table. We summarised the findings in <a href="./full#CD007574-tbl-0001">summary of findings Table 1</a> using the GRADE approach as described in Chapter 14 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007574-bbs2-0038" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s).Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Higgins 2021</a>). We included the following outcomes in the summary of findings table. </p> <p> <ul id="CD007574-list-0013"> <li> <p>Favourable functional outcome at the end of follow‐up</p> </li> <li> <p>Death from all causes in the acute phase and at the end of follow‐up</p> </li> <li> <p>Symptomatic intracranial haemorrhage in the acute phase and at the end of follow‐up</p> </li> <li> <p>Neurological status at end of follow‐up</p> </li> <li> <p>Degree of recanalisation</p> </li> </ul> </p> <p>We planned to downgrade the certainty of evidence based on the five GRADE domains (study limitations, imprecision, inconsistency, indirectness, and publication bias) where required and to justify all decisions to downgrade the certainty of evidence. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007574-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007574-sec-0041"></div> <section id="CD007574-sec-0042"> <h3 class="title">Description of studies</h3> <p>We included 19 studies involving a total of 3793 participants randomised to either endovascular thrombectomy or intra‐arterial interventions, or a combination of these two endovascular treatments, or control (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). This review update includes 15 new RCTs. The previous version included four trials with 350 participants (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>). There was no statistically significant heterogeneity between the trials included in this review, therefore we deemed a fixed‐effect meta‐analysis to be appropriate. A total of 20 participants were lost to follow‐up across all 19 studies. </p> <section id="CD007574-sec-0043"> <h4 class="title">Types and severities of strokes</h4> <p>Three studies included participants with middle cerebral artery territory strokes (<a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>). <a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a> and <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a> included participants with posterior circulation strokes. <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a> included participants with large‐vessel, anterior circulation strokes. <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>, <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>, and <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a> included participants with both anterior and posterior circulation strokes. <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a> included participants with large vessel ischaemic stroke because of a thrombus length of over 8 mm in the anterior circulation. Eight trials included participants with proximal artery occlusion strokes in the anterior circulation (<a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>). <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a> and <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a> included participants with occlusion of the intracranial internal carotid artery or proximal middle cerebral artery. <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a> included participants in the extended time window from six up to 24 hours after last known to be well. <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a> included participants in the extended time window from six to 16 hours after last known to be well. See <a href="./references#CD007574-sec-0107" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD007574-sec-0044"> <h4 class="title">Age and gender of participants</h4> <p>One study included participants aged 18 to 75 years (<a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>). Eight studies included participants aged 18 to 80/85 years (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). Seven studies included participants from age 18 years without any upper age limit (<a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>). One study included participants aged 18 to 90 years (<a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>). </p> <p>Mean ages of participants were as follows.</p> <p> <ul id="CD007574-list-0014"> <li> <p>64 years (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>). </p> </li> <li> <p>65 years (<a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>). </p> </li> <li> <p>66 years (<a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>). </p> </li> <li> <p>67 years (<a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>). </p> </li> <li> <p>69 years (<a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>). </p> </li> </ul> </p> <p>The median age of participants in <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a> was 70 years. There was no age imbalance between the intervention and control groups in any of the trials. </p> <p>Of participants in all 19 included studies, 1093 of 2052 (53%) in the intervention group were men and 941 of 1761 (53%) in the control group were men, so overall there was no significant sex imbalance. There were gender imbalances in six studies (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>). </p> </section> <section id="CD007574-sec-0045"> <h4 class="title">Medical history of participants</h4> <p>For information on the medical backgrounds of participants, see <a href="./references#CD007574-sec-0107" title="">Characteristics of included studies</a>. There were small imbalances for diabetes mellitus in <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>, congestive heart failure in <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>, and coronary heart disease in <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>. In eight studies conventional vascular risk factors were well balanced amongst the treatment and control groups (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>). </p> </section> <section id="CD007574-sec-0046"> <h4 class="title">Stroke mechanism</h4> <p>The predominant mechanism of stroke in the included studies was classified as cardioembolism, followed by carotid atheroembolism and unknown mechanism. Lacunar infarcts were not excluded. The proportion of cardioembolic strokes ranged from around 50% in <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a> to around 85% in <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>. Fourteen studies did not provide data on stroke mechanism (<a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). </p> </section> <section id="CD007574-sec-0047"> <h4 class="title">Findings on CT or MRI at randomisation</h4> <p>In <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a> and <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>, most participants had early ischaemic changes on CT, and a minority of participants in these two studies (8%) had ischaemic changes comprising more than one‐third of the middle cerebral artery territory. Patients were not excluded from <a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a> on the basis of baseline ischaemic CT abnormalities, and in <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a> patients with CT abnormalities consistent with subtle early ischaemia in the insular cortex, frontal and temporal opercula, or lenticular nuclei were included. </p> <p>In <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>, participants were randomised based on the presence or absence of penumbra on CT or MRI. In <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>, patients were included if a proximal arterial occlusion in the anterior cerebral circulation was confirmed on CT angiography, MRI angiography, or digital subtraction angiography. In <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>, patients were included if an occluded proximal occlusion was observed on CT angiography. Patients with large early ischaemic changes on plain CT (defined as ASPECTS ≤ 5) were excluded. In <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>, patients were included if CT angiography showed occluded internal carotid or middle cerebral artery, and there was evidence of ischaemic penumbra on CT perfusion. In <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>, patients were included if CT angiography showed occlusion of the internal carotid or first segment of the middle cerebral artery, and there was evidence of an ischaemic penumbra on CT perfusion. In <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>, patients with large infarction cores (defined as ASPECTS &lt; 7 on CT or &lt; 6 on MRI) were excluded. In <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>, plain CT and neurological deficits were used to include patients who had an 80% likelihood of proximal occlusion strokes. The trial was amended after 284 participants were randomised to allow the use of CT angiography to identify patients with proximal occlusion strokes. In <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>, patients were enrolled if CT or MR angiography identified occlusion of the internal carotid, M1 or single proximal M2. In <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>, patients were included if CT perfusion or MRI diffusion and perfusion scans showed an initial infarct volume (ischaemic core) of less than 70 mL, a ratio of volume of ischaemic tissue to initial infarct volume of 1.8 or more, and an absolute volume of potentially reversible ischaemia (penumbra) of 15 mL or more. In <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>, CT angiography was required to confirm intracranial occlusion and to rule out tandem cervical occlusion that would prevent thrombectomy without treatment. Enhanced thin‐section CT scan was also used to demonstrate over 8‐millimetre clot length. However, advanced perfusion imaging selection or multiphase CT or CT angiography was not required. In <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>, patients were eligible for inclusion in the trial if they had evidence of occlusion of the intracranial internal carotid artery, the first segment of the middle cerebral artery, or both, on CT angiography or magnetic resonance angiography. In <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>, occlusions had to be confirmed by CT or magnetic resonance angiography. In <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>, all suspected or proven occlusions of the M1 or M2 segments of the middle cerebral artery, supraclinoid internal carotid artery, or basilar artery were included. Vascular imaging was not mandated in the protocol. In <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>, patients were eligible for inclusion if they had occlusion of the basilar artery confirmed by CT angiography, MRI, or digital subtraction angiography. Patients with occlusion of the distal intracranial vertebral artery (V4 segment) resulting in no flow to the basilar artery were also included. No evidence of intracranial haemorrhage, significant cerebellar mass effect, acute hydrocephalus, or extensive bilateral brainstem ischaemia should be found on CT or MRI. In <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>, patients were eligible for inclusion in the study if they had an occlusion involving the intracranial internal carotid artery, the first segment of the middle cerebral artery (M1), or both. The main imaging exclusion criteria were evidence of recent intracranial haemorrhage; the presence of a large infarct, as defined by ASPECTS &lt; 6 on CT or &lt; 5 on diffusion weighted MRI; and the complete absence of leptomeningeal collaterals on CT angiography. If CT or MRI perfusion was performed, participants had to have a baseline infarct volume of less than 70 mL, a ratio of volume of ischaemic tissue to baseline infarct volume of 1.8 or more, and an absolute volume of potentially reversible ischaemia (penumbra) of 15 mL or more. </p> </section> <section id="CD007574-sec-0048"> <h4 class="title">Time to randomisation</h4> <p>The protocol‐defined time between onset of stroke and inclusion in the trial varied from three to 24 hours. One trial included participants up to three hours after stroke onset (<a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>); two trials included participants up to 4.5 hours after stroke onset (<a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>); two trials included participants up to five hours after stroke onset (<a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>); six trials included participants up to six hours after stroke onset (<a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>); four trials included participants up to eight hours after stroke onset (<a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>); one trial included participants up to 12 hours after stroke onset (<a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>); one trial included participants from six to 16 hours after last to be known well (<a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>); and two trials included participants up to 24 hours after stroke onset (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>). </p> <p>The actual times to randomisation or start of therapy were variably reported. Time to randomisation was not reported in <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>. The time to actual delivery of endovascular thrombectomy (not start of procedure) in <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a> was a median 5.4 hours for the treatment group and 5.7 hours for the control group. In <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>, the time to randomisation was a median 4.7 hours in the treatment group and 5.1 hours in the control group. In <a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>, the onset to treatment time was a mean 11.8 hours in the treatment group and 12.5 hours in the control group. In <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>, the onset to randomisation time was a mean 3.3 hours in the treatment group and 3.4 hours in the control group. In <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>, the onset to randomisation time was 5.3 hours in the treatment group and 5.8 hours in the control group. In <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>, the onset to randomisation time was three hours in both groups. In <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>, the onset to randomisation time was 3.4 hours in both groups. In <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a> and <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>, the onset to randomisation time was 2.8 hours in both groups. The onset to randomisation time was not reported in <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a> and <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>. In <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>, the time to actual delivery of endovascular thrombectomy or intravenous thrombolytic therapy (not start of procedure) was 4.2 hours in the treatment group. In <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>, the median time from stroke onset to groin puncture was 3.5 hours in the treatment group. In <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>, the median time interval between the time that the participant was last known to be well and randomisation was 12.2 hours in the treatment group. In <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>, stroke onset to randomisation time was reported as 181 minutes. In <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>, time from stroke onset to randomisation was not reported, but the authors reported that 50% of participants in the treatment group were randomised within three hours of stroke onset. In <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>, time from stroke onset to randomisation was a median 168 minutes in the treatment group. In <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>, median time from stroke onset to randomisation was 10 hours and 53 minutes in the treatment group. </p> <p>Participants in nine studies, <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>, were randomised earlier than participants in six studies (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>). </p> </section> <section id="CD007574-sec-0049"> <h4 class="title">Method of recanalisation</h4> <p>Four trials tested only intra‐arterial interventions with either the drug urokinase or pro‐urokinase to achieve thrombolysis (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>). There were differences between these trials in dose, form, and method of drug delivery. See <a href="./references#CD007574-sec-0107" title="">Characteristics of included studies</a> table. No participants in these four studies were given intravenous thrombolytic treatment (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>). </p> <p>Five trials approved the use of both mechanical thrombectomy and intra‐arterial interventions (<a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). In <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>, intra‐arterial treatment consisted of arterial catheterisation with a microcatheter to the level of occlusion and delivery of a thrombolytic agent, or mechanical thrombectomy was performed, or both, with the method used left to the discretion of the local interventionist. In this study either alteplase at a maximum dose of 90 mg or urokinase 1,200,000 international units (IU) was used for intra‐arterial thrombolysis in the case of intra‐arterial treatment. In <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>, the approach used was chosen by the local neurointerventionist and encompassed receiving mechanical thrombectomy or endovascular delivery of tissue plasminogen activator (tPA) by means of microcatheter. In <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a> and <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>, intra‐arterial interventions were approved as rescue therapy. In <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>, intra‐arterial interventions of maximum 0.3 mg/kg were approved in cases of persistent distal occlusions. </p> <p>Mechanical clot disruption was prohibited by the protocol in <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a> and did not occur in <a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>. The protocols of eight trials permitted use of mechanical clot disruption, either using a guidewire or by employing stents or other devices (<a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>). In <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a> and <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>, participants were primarily treated with first‐generation mechanical devices (i.e. Merci and Penumbra systems). The majority of participants were treated with stent retrievers in 10 trials (<a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>). In <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>, any US Food and Drug Administration (FDA)‐approved thrombectomy device was allowed to perform thrombectomy. In <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>, thrombectomy was performed with the use of the Trevo device, a retrievable self‐expanding stent. No other devices or intra‐arterial pharmacological agents were allowed. In <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>, any device on the list from the trial's regularly updated list that was also approved by the ethics committee and the French National Agency for the Safety of Medicines and Health Products could be chosen. The following devices were used: Merci, Penumbra, Catch, and Solitaire. In <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>, thrombectomy was performed using an approved device according to local practice. In <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>, aspiration thrombectomy was performed using the Penumbra system and included the Separator 3D after December 2012, and the larger‐bore ACE aspiration catheter after August 2013. In <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>, thrombectomy was performed with the Solitaire FR stent retriever or Penumbra aspiration system. Angioplasty and stenting of the cervical internal carotid artery could be performed if necessary. Standard medical care included the use of alteplase, following the guidelines of the Brazilian Stroke Society and the American Heart Association. In <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>, participants received intravenous alteplase if they met the criteria for intravenous thrombolysis within 4.5 hours of stroke symptom onset as per existing guidelines. Mechanical thrombectomy was performed with stent retriever (preferred choice) or thrombo‐aspiration devices. Ten trials used only endovascular mechanical thrombectomy and no intra‐arterial thrombolysis (<a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>). </p> <p>A total of 445 participants (89%) from <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>, 44 participants (37%) from <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>, 18 participants (10%) from <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>, 46 participants (60%) from <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>, 150 participants (73%) from <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>, 18 participants (9%) from <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>, and 238 participants (75%) from <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a> were given intravenous thrombolytic treatment before randomisation. The inclusion criteria of six studies specified that all participants should be given intravenous thrombolytic treatment as a bridging to intra‐arterial treatment (<a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). </p> </section> <section id="CD007574-sec-0050"> <h4 class="title">Concomitant use of antithrombotic treatment</h4> <p>The protocols for concomitant antithrombotic therapy varied amongst trials. There may have been an imbalance in the use of antithrombotic therapy in <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>, where safety concerns prompted an alteration of the concomitant antithrombotic regimen during the trial. Similarly, the <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a> protocol specified that heparin, warfarin, and aspirin should not be given for 24 hours in the treatment group. In <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>, participants who had not received intravenous alteplase could receive therapy with antiplatelet agents after 24 hours postrandomisation. Standard medical care was provided in accordance with local guidelines. Ten studies did not report differences between the intervention and the control group in the use of antiplatelet or treatment with alteplase (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>). </p> <p>There were also differences in the use of heparin. In <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>, participants in both the intervention and control groups received heparin. In 11 studies heparin was only given to participants in the intervention group who underwent angiography (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>). </p> </section> <section id="CD007574-sec-0051"> <h4 class="title">Assessment of outcome</h4> <p>All studies reported death at the end of follow‐up. Data were available for deaths in the acute phase from one study (<a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>). Functional outcome was assessed using the modified Rankin scale (mRS) in all included studies. All studies provided data on mRS score 0 to 2, with the exception of <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>, which only provided data on mRS score 0 to 1. All studies except <a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a> collected the outcomes of interest at 90 days. </p> <p>The methods of determination of intracranial haemorrhage varied and are provided in the <a href="./references#CD007574-sec-0107" title="">Characteristics of included studies</a> table. </p> <p>Nine studies reported recanalisation using the thrombolysis in cerebral infarction (TICI) or modified TICI classification (<a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>). TICI grade 3 is complete perfusion, and TICI grade 2 is partial perfusion. <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a> reported recanalisation as: </p> <p> <ol id="CD007574-list-0015"> <li> <p>complete;</p> </li> <li> <p>partial and less than 50% in the affected territory;</p> </li> <li> <p>partial and at least 50% in the affected territory; and</p> </li> <li> <p>no recanalisation.</p> </li> </ol> </p> <p><a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a> did not prespecify criteria for judging recanalisation, although recanalisation at days 7 to 10 was a prespecified secondary outcome. Recanalisation was described as either complete or partial. </p> </section> <section id="CD007574-sec-0052"> <h4 class="title">Results of the search</h4> <p>The search yielded 11,062 articles, of which four studies were included in the previous version of this review (<a href="./references#CD007574-bbs2-0048" title="O'RourkeK , BergeE , WalshCD , KellyPJ .Percutaneous vascular interventions for acute ischaemic stroke. Cochrane Database of Systematic Reviews2010, Issue 10. Art. No: CD007574. [DOI: 10.1002/14651858.CD007574.pub2]">O'Rourke 2010</a>). A total of 57 articles were assessed as potentially eligible and retrieved in full text. We excluded 31 studies because they were not RCTs of endovascular stroke therapies. Upon closer examination of the remaining 26 studies, we excluded seven studies because they compared endovascular therapy with other therapies (such as intravenous thrombolytic treatment) and were not eligible for inclusion in the present meta‐analysis (<a href="./references#CD007574-bbs2-0020" title="DucrocqX , BracardS , TaillandierL , AnxionnatR , LacourJC , GuilleminF , et al.Comparison of intravenous and intra-arterial urokinase thrombolysis for acute ischaemic stroke. Journal of Neuroradiology2005;32:26-32. ">Ducrocq 2005</a>; <a href="./references#CD007574-bbs2-0021" title="KerisV , RudnickaS , VoronaV , EninaG , TilgaleB , FricbergsJ .Combined intra-arterial/intravenous thrombolysis for acute ischemic stroke. American Journal of Neuroradiology2001;22:352-8. ">Keris 2001</a>; <a href="./references#CD007574-bbs2-0022" title="LewandowskiCA , FrankelM , TomsickTA , BroderickJ , FreyJ , ClarkW , et al.Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke1999;30:2598-605. ">Lewandowski 1999</a>; <a href="./references#CD007574-bbs2-0023" title="SenS , HuangDY , AkhavanO , WilsonS , VerroP , SolanderS , et al.IV vs IA TPA in acute ischemic stroke with CT angiographic evidence of major vessel occlusion: a feasibility study. Neurocritical Care2009;11:76-81. ">Sen 2009</a>; <a href="./references#CD007574-bbs2-0024" title="CicconeA , ValvassoriL , NichelattiM , SgoifoA , PonzioM , SterziR , et al.Endovascular treatment for acute ischemic stroke. New England Journal of Medicine2013;368:904‐13. ">SYNTHESIS Expansion 2013</a>; <a href="./references#CD007574-bbs2-0025" title="CicconeA , ValvassoriL , PonzioM , BallabioM , GasparottiR , SessaM , et al.Intra‐arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial. Journal of Neurointerventional Surgery2010;2:74‐9. ">SYNTHESIS pilot 2010</a>; <a href="./references#CD007574-bbs2-0026" title="WolfeT , SuarezJI , TarrRW , WelterE , LandisD , SunshineJL , et al.Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases2008;17:121-8. ">Wolfe 2008</a>).  </p> <p>We identified six ongoing studies (<a href="./references#CD007574-bbs2-0027" title="ISRCTN19922220.Endovascular treatment of acute ischemic stroke in the Netherlands for late arrivals. www.isrctn.com/ISRCTN19922220 (first received 11 December 2017). [DOI: 10.1186/ISRCTN19922220]">ISRCTN19922220</a>; <a href="./references#CD007574-bbs2-0028" title="NCT01717755.Basilar Artery International Cooperation Study (BASICS). clinicaltrials.gov/ct2/show/NCT01717755 (first received 30 October 2012). ">NCT01717755</a>; <a href="./references#CD007574-bbs2-0029" title="NCT01852201.POSITIVE Stroke Clinical Trial. clinicaltrials.gov/ct2/show/NCT01852201 (first received 13 May 2013). ">NCT01852201</a>; <a href="./references#CD007574-bbs2-0030" title="NCT02419781.Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan RCT. clinicaltrials.gov/ct2/show/NCT02419781 (first received 17 April 2015). ">NCT02419781</a>; <a href="./references#CD007574-bbs2-0031" title="NCT03094715.Efficacy and safety of thrombectomy in stroke with extended lesion and extended time window (TENSION). clinicaltrials.gov/ct2/show/NCT03094715 (first received 29 March 2017). ">NCT03094715</a>; <a href="./references#CD007574-bbs2-0032" title="NCT03805308.The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior circulation ischemic stroke (TESLA). clinicaltrials.gov/ct2/show/NCT03805308 (first received 15 January 2019). ">NCT03805308</a>). </p> <p>A PRISMA study flow diagram is shown in <a href="#CD007574-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD007574-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA study flow diagram." data-id="CD007574-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA study flow diagram.</p> </div> </div> </div> </section> <section id="CD007574-sec-0053"> <h4 class="title">Included studies</h4> <p>We included 19 studies in the review (see <a href="./references#CD007574-sec-0107" title="">Characteristics of included studies</a>) (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). </p> <p>All trials except <a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a> collected the outcomes of interest at 90 days' follow‐up. </p> </section> <section id="CD007574-sec-0054"> <h4 class="title">Excluded studies</h4> <p>We excluded seven studies (see <a href="./references#CD007574-sec-0108" title="">Characteristics of excluded studies</a>) (<a href="./references#CD007574-bbs2-0020" title="DucrocqX , BracardS , TaillandierL , AnxionnatR , LacourJC , GuilleminF , et al.Comparison of intravenous and intra-arterial urokinase thrombolysis for acute ischaemic stroke. Journal of Neuroradiology2005;32:26-32. ">Ducrocq 2005</a>; <a href="./references#CD007574-bbs2-0021" title="KerisV , RudnickaS , VoronaV , EninaG , TilgaleB , FricbergsJ .Combined intra-arterial/intravenous thrombolysis for acute ischemic stroke. American Journal of Neuroradiology2001;22:352-8. ">Keris 2001</a>; <a href="./references#CD007574-bbs2-0022" title="LewandowskiCA , FrankelM , TomsickTA , BroderickJ , FreyJ , ClarkW , et al.Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke1999;30:2598-605. ">Lewandowski 1999</a>; <a href="./references#CD007574-bbs2-0023" title="SenS , HuangDY , AkhavanO , WilsonS , VerroP , SolanderS , et al.IV vs IA TPA in acute ischemic stroke with CT angiographic evidence of major vessel occlusion: a feasibility study. Neurocritical Care2009;11:76-81. ">Sen 2009</a>; <a href="./references#CD007574-bbs2-0024" title="CicconeA , ValvassoriL , NichelattiM , SgoifoA , PonzioM , SterziR , et al.Endovascular treatment for acute ischemic stroke. New England Journal of Medicine2013;368:904‐13. ">SYNTHESIS Expansion 2013</a>; <a href="./references#CD007574-bbs2-0025" title="CicconeA , ValvassoriL , PonzioM , BallabioM , GasparottiR , SessaM , et al.Intra‐arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial. Journal of Neurointerventional Surgery2010;2:74‐9. ">SYNTHESIS pilot 2010</a>; <a href="./references#CD007574-bbs2-0026" title="WolfeT , SuarezJI , TarrRW , WelterE , LandisD , SunshineJL , et al.Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases2008;17:121-8. ">Wolfe 2008</a>). </p> </section> </section> <section id="CD007574-sec-0055"> <h3 class="title">Risk of bias in included studies</h3> <p>The quality of randomisation was adequate in 15 studies (<a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). The quality of randomisation was unclear in four studies, as the studies did not report the precise methodology of sequence generation (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>). </p> <p>A total of 20 participants were lost to follow‐up in the 19 included trials. One trial did not report ITT analyses (<a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007574.pub2/references#CD007574-bbs2-0003" target="_blank">PROACT 1 1998</a>), and one trial did not report on their prespecified secondary outcomes (<a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007574.pub2/references#CD007574-bbs2-0001" target="_blank">AUST 2005</a>). </p> <p>Sixteen trials were terminated early either due to efficacy or lack of equipoise and consequently suffered from a lack of statistical power (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). For details, see <a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007574.pub2/references#CD007574-sec2-0011" target="_blank">Characteristics of included studies</a>. </p> <section id="CD007574-sec-0056"> <h4 class="title">Allocation</h4> <p>The quality of randomisation was adequate in 15 studies (<a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). The quality of randomisation was unclear in four studies, as the studies did not report the precise methodology of sequence generation (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>). </p> <p>We assessed 16 studies as at low risk of bias (<a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>), and three studies as at unclear risk of bias (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>). </p> </section> <section id="CD007574-sec-0057"> <h4 class="title">Blinding</h4> <p>In only one trial (<a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>) were the participants and personnel blinded for treatment. We assessed the other 18 studies to be of unclear risk of bias (perfomance bias) (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). Even though the nature of the intervention makes it difficult both practically and ethically to perform double‐blind studies this is a source of bias. We assessed 17 studies to be at low risk of bias (detection bias) (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>), and two studies to be of high risk of bias (<a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). In <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>, all data and outcome measures were collected by unblinded routine care personnel, and in <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>, outcome assessment was performed by vascular neurologists not masked to the allocated treatment. </p> </section> <section id="CD007574-sec-0058"> <h4 class="title">Incomplete outcome data</h4> <p>We assessed 13 studies as at low risk (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>); four trials as at an unclear risk (<a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>); and two trials as at high risk of attrition bias (<a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>). <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a> presented per‐protocol analyses, and nine participants were excluded from the analyses (five did not have target lesion on vessel imaging; two did not have post‐tPA vessel imaging; and two had failed perfusion imaging). <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a> did not report the primary efficacy outcome for six randomised but untreated participants (i.e. an on‐treatment rather than the preferred ITT analysis). Of these six participants, five were in the treatment group, representing 16% of the total randomised treatment group; the remaining randomised but untreated participant was in the placebo group. Given the possibility that the five participants randomised to the treatment group who did not receive treatment represented a subgroup of non‐responders, this may have had the effect of enriching the treatment group with responders and biasing the results in favour of treatment. The primary safety outcome was reported for these six participants, therefore we do not consider that the safety analysis was prone to on‐treatment bias. </p> </section> <section id="CD007574-sec-0059"> <h4 class="title">Selective reporting</h4> <p>Four studies were not analysed according to the ITT principle (<a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>). We assessed 17 studies to be at low risk (<a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>), and one study to be at unclear risk of reporting bias (<a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). We assessed one study to be at high risk of bias because this trial did not report prespecified secondary outcomes (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>). Baseline angiographic findings were not reported for two participants. There was no a priori requirement for follow‐up imaging in this study. </p> <p>We explored publication bias by inspecting the funnel plot (<a href="#CD007574-fig-0002">Figure 2</a>). We considered the funnel plot visually symmetric. </p> <div class="figure" id="CD007574-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: Favourable functional outcome at end of follow‐up (functional outcome: mRS 0 to 2)." data-id="CD007574-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: Favourable functional outcome at end of follow‐up (functional outcome: mRS 0 to 2). </p> </div> </div> </div> </section> <section id="CD007574-sec-0060"> <h4 class="title">Other potential sources of bias</h4> <p>A total of 20 participants were lost to follow‐up in the 19 included studies. Sixteen trials were terminated early either due to efficacy or lack of equipoise, and thus suffered from a lack of statistical power (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). We assessed eight studies to be at low risk (<a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>), and 11 studies to be at unclear risk of other bias (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>). We assessed one study to be at high risk of other bias (<a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>). This study did not report the primary efficacy outcome for six randomised but untreated participants (i.e. an on‐treatment rather than the preferred ITT analysis). Of these six participants, five were in the treatment group, representing 16% of the total randomised treatment group; the remaining randomised but untreated participant was in the placebo group. Given the possibility that the five participants randomised to the treatment group who did not receive treatment represented a subgroup of non‐responders, this may have had the effect of enriching the treatment group with responders and biasing the results in favour of treatment. The primary safety outcome was reported for these six participants, therefore we do not consider that the safety analysis was prone to on‐treatment bias. Any on‐treatment bias due to these six participants would be diluted in the overall analysis. Also, this trial was stopped early by the sponsor to determine whether there was sufficient evidence of safety and efficacy to support continuation of a longer‐term programme, which was ultimately expressed in the form of the phase III <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a> trial. No safety concerns were involved in that decision. An analysis of the data set from all participants who underwent angiography by a biostatistical unit independent of the conduct of the trial forms the basis of the published <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a> report. At the time of termination, the <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a> trial had achieved 89% of its target sample size. The implications are difficult to interpret. As a general principle, trials that are stopped for any reason other than according to specific predefined stopping rules are theoretically prone to bias. However, it remains unclear whether this factor introduced any bias in this particular case. </p> </section> </section> <section id="CD007574-sec-0061"> <h3 class="title" id="CD007574-sec-0061">Effects of interventions</h3> <p>See: <a href="./full#CD007574-tbl-0001"><b>Summary of findings 1</b> Endovascular thrombectomy interventions compared to standard therapy for acute ischaemic stroke</a> </p> <section id="CD007574-sec-0062"> <h4 class="title">Favourable functional outcome at the end of follow‐up</h4> <p>For mRS 0 to 2, data were available for a total of 3715 participants from 18 trials (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). There was overall an effect in favour of treatment (risk ratio (RR) 1.50, 95% confidence interval (CI) 1.37 to 1.63; 3715 participants, 18 RCTs; high‐certainty evidence) with moderate between‐study heterogeneity (I<sup>2 </sup>= 56%) (<a href="./references#CD007574-fig-0003" title="">Analysis 1.1</a>). </p> <p>For mRS 0 to 1, data were available for a total of 3632 participants from 18 trials (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). There was a high effect in favour of treatment (RR 1.61, 95% CI 1.42 to 1.82, 3632 participants, 18 RCTs) with moderate between‐study heterogeneity (I<sup>2 </sup>= 38%) (<a href="./references#CD007574-fig-0004" title="">Analysis 1.2</a>). </p> </section> <section id="CD007574-sec-0063"> <h4 class="title">Death from all causes at the end of follow‐up</h4> <p>Data were available for a total of 3793 participants from all 19 trials (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). There was a reduced risk of death in the treatment group (RR 0.85, 95% CI 0.75 to 0.97; 3793 participants, 19 RCTs; high‐certainty evidence) with little between‐study heterogeneity (I<sup>2 </sup>= 0%) (<a href="./references#CD007574-fig-0005" title="">Analysis 2.1</a>). </p> </section> <section id="CD007574-sec-0064"> <h4 class="title">Death from all causes during the acute phase</h4> <p>Data were available for a total of 1243 participants from three trials (<a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>). There was no evidence of an effect of treatment on deaths in the acute phase (RR 1.06, 95% CI 0.77 to 1.47; 1243 participants, 3 RCTs) with I<sup>2 </sup>= 0% (<a href="./references#CD007574-fig-0006" title="">Analysis 2.2</a>). </p> </section> <section id="CD007574-sec-0065"> <h4 class="title">Symptomatic intracranial haemorrhage during the acute phase</h4> <p>Data were available for a total of 1559 participants from six trials (<a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). We observed no excess risk of symptomatic intracranial haemorrhage in the treatment group (RR 1.46, 95% CI 0.91 to 2.36; 1559 participants, 6 RCTs) with very little between‐study heterogeneity (I<sup>2 </sup>= 0%) (<a href="./references#CD007574-fig-0007" title="">Analysis 3.1</a>). </p> </section> <section id="CD007574-sec-0066"> <h4 class="title">Symptomatic intracranial haemorrhage at the end of follow‐up</h4> <p>Data were available for a total of 1752 participants from 10 trials (<a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>). We observed no excess risk of intracranial haemorrhage in the treatment group (RR 1.05, 95% CI 0.72 to 1.52; 1752 participants, 10 RCTs; high‐certainty evidence) with no between‐study heterogeneity (I<sup>2 </sup>= 0%) (<a href="./references#CD007574-fig-0008" title="">Analysis 3.2</a>). </p> </section> <section id="CD007574-sec-0067"> <h4 class="title">Neurological outcome at the end of follow‐up</h4> <p>NIHSS data were available for a total of 334 participants from three trials (<a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>). There was an effect in favour of treatment (RR 2.03, 95% CI 1.21 to 3.40; 334 participants, 3 RCTs; moderate‐certainty evidence) with no between‐study heterogeneity (I<sup>2 </sup>= 0%) (<a href="./references#CD007574-fig-0009" title="">Analysis 4.1</a>). </p> </section> <section id="CD007574-sec-0068"> <h4 class="title">Degree of recanalisation</h4> <p>Data on complete recanalisation (TIMI grade 3) were available for 198 participants from two trials (<a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>). For TIMI grade 3, there was an overall effect in favour of treatment (RR 8.25, 95% CI 1.63 to 41.90; 198 participants, 2 RCTs; moderate‐certainty evidence) with no between‐study heterogeneity (I<sup>2 </sup>= 0%) (<a href="./references#CD007574-fig-0010" title="">Analysis 5.1</a>). </p> <p>Data on complete or complete or partial recanalisation (TICI grade 2 or 3) were available for 974 participants randomised to treatment from 10 trials (<a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>), and for 99 participants randomised to control from three trials (<a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>). In the three trials that provided data on TIMI 2 or 3 for both the treatment group and the controls (total 268 participants) (<a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>), there was an effect in favour of treatment (RR 3.11, 95% CI 2.18 to 4.42; P &lt; 0.00001; 268 participants, 3 RCTs) with moderate between‐study heterogeneity (I<sup>2</sup> = 48%) <a href="./references#CD007574-fig-0011" title="">Analysis 5.2</a>. </p> </section> <section id="CD007574-sec-0069"> <h4 class="title">Major extracranial haemorrhage during the acute phase</h4> <p>In <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>, two participants had severe injection site haemorrhages; however, the allocation of these participants was unclear. No participants in <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a> had major extracranial haemorrhage in the acute phase. In <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>, three participants had groin haematoma, and in <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>, one participant in the intervention group had groin haematoma. In <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>, one participant had access‐site complications leading to intervention. In <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>, three participants in the intervention group had haematomas at the access site. In <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>, one participant had groin/retroperitoneal haematoma and was given a blood transfusion. In <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>, two participants in the control group had major extracranial haemorrhage. In <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>, five participants in the control group had extracranial haemorrhage. It was unclear whether any participants in the following nine studies  had major extracranial haemorrhages in the acute phase: <a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>. </p> </section> <section id="CD007574-sec-0070"> <h4 class="title">Subgroup analyses</h4> <section id="CD007574-sec-0071"> <h5 class="title">Age and sex</h5> <p>There was no difference in the effects of the intervention between younger and older participants in the nine trials that provided subgroup data on age (RR 1.72, 95% CI 1.48 to 2.0 versus RR 1.49, 95% CI 1.18 to 1.87; P for interaction = 0.29) (<a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). The cutoff for younger and older participants varied between the trials, from 66 years in <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a> to 80 years in <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a> and <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a> (<a href="./references#CD007574-fig-0012" title="">Analysis 6.1</a>). </p> <p>There were no differences in the effects of the intervention between women and men in the seven trials that provided subgroup data on sex (RR 1.67, 95% CI 1.37 to 2.04 versus RR 1.63, 95% CI 1.34 to 1.98; P for interaction = 0.85) (<a href="./references#CD007574-fig-0013" title="">Analysis 6.2</a>) (<a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). </p> </section> <section id="CD007574-sec-0072"> <h5 class="title">Stroke severity</h5> <p>Participants with higher NIHSS scores had a better effect of the intervention than participants with lower NIHSS scores in the nine trials that provided subgroup data on NIHSS score (RR 1.42, 95% CI 1.22 to 1.66 versus RR 2.0, 95% CI 1.57 to 2.55; P for interaction = 0.02) (<a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). The cutoff for NIHSS score varied from 17 to 21 (<a href="./references#CD007574-fig-0014" title="">Analysis 6.3</a>). </p> </section> <section id="CD007574-sec-0073"> <h5 class="title">Early ischaemic change</h5> <p>There was a better effect of the intervention in participants with more pronounced early ischaemic changes on CT (lower ASPECTS) than in those with less early ischaemic changes on CT (higher ASPECTS) in the six trials that provided subgroup data on ASPECTS (RR 2.01, 95% CI 1.53 to 2.66 versus RR 1.39, 95% CI 1.19 to 1.62; P for interaction = 0.02) (<a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>). The cutoff for ASPECTS varied from 7 in <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a> and <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a> to 8 in <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>, <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>, and <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a> (<a href="./references#CD007574-fig-0015" title="">Analysis 6.4</a>). </p> </section> <section id="CD007574-sec-0074"> <h5 class="title">Time to intervention</h5> <p>There was no difference between the effect of intervention in trials with a shorter mean or median time (&lt; 250 minutes) to start of intervention (RR 1.67, 95% CI 1.40 to 2.00) (<a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>); medium time (250 to 300 minutes) (RR 1.30, 95% CI 1.11 to 1.51) (<a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>); and longer time (&gt; 300 minutes) to start of intervention (RR 1.41, 95% CI 0.97 to 2.04; P for interaction = 0.10) (<a href="./references#CD007574-fig-0016" title="">Analysis 6.5</a>) (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>). </p> </section> <section id="CD007574-sec-0075"> <h5 class="title">Intravenous thrombolytic treatment before randomisation</h5> <p>There was no difference in the effect of the intervention between participants who had been given intravenous thrombolytic treatment compared to those who had not been given intravenous thrombolytic treatment before randomisation in the four trials that provided subgroup data on thrombolytic treatment (RR 1.95, 95% CI 1.55 to 2.46 versus RR 2.18, 95% CI 1.37 to 3.47; P = 0.67) (<a href="./references#CD007574-fig-0017" title="">Analysis 6.6</a>) (<a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>). </p> </section> <section id="CD007574-sec-0076"> <h5 class="title">Method of recanalisation</h5> <p>There were differences between the effect of the intervention in trials where participants were treated with intra‐arterial thrombolysis alone without any endovascular mechanical thrombectomy (RR 1.47, 95% CI 1.08 to 1.99) (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>); trials where a majority of participants were treated with first‐generation mechanical devices other than stent retrievers (e.g. Merci and Penumbra systems) (RR 1.05, 95% CI 0.87 to 1.27) (<a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>); and trials where a majority of participants were treated with stent retrievers (RR 1.80, 95% CI 1.59 to 2.04; P for interaction &lt; 0.001) (<a href="./references#CD007574-fig-0018" title="">Analysis 6.7</a>) (<a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>). </p> </section> <section id="CD007574-sec-0077"> <h5 class="title">Proximity of vascular occlusion</h5> <p>There was a larger effect of the intervention in trials that included primarily proximal occlusion strokes, <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>, than in trials that included both proximal and non‐proximal occlusion strokes, <a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a> (RR 1.71, 95% CI 1.47 to 1.99 versus RR 1.16, 95% CI 0.99 to 1.37; P for interaction &lt; 0.001) (<a href="./references#CD007574-fig-0019" title="">Analysis 6.8</a>). </p> </section> <section id="CD007574-sec-0078"> <h5 class="title">Infarct localisation</h5> <p>Some studies provided data on subgroups of stroke, but we were unable to compare these subgroups because of different definitions of stroke locations in each study (<a href="./references#CD007574-fig-0020" title="">Analysis 6.9</a>). Only one trial included participants with basilar artery occlusions (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>), but the sample size for this trial was too small for subgroup analyses. </p> </section> <section id="CD007574-sec-0079"> <h5 class="title">Patient selection based on penumbra imaging</h5> <p>There was no difference in the effect of intervention between trials that used penumbra imaging for selection of patients to treatment (RR 2.24, 95% CI 1.45 to 3.46) <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>, and trials that did not use penumbra imaging (RR 1.72, 95% CI 1.42 to 2.08; P for interaction = 0.27) (<a href="./references#CD007574-fig-0021" title="">Analysis 6.10</a>) (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>). </p> </section> </section> <section id="CD007574-sec-0080"> <h4 class="title">Sensitivity analyses</h4> <p>There was no difference in participants with good functional outcome between trials included the previous version of the review (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>), compared with trials included in the current review (RR 1.47, 95% CI 1.08 to 1.99 versus RR 1.50, 95% CI 1.37 to 1.63; P for interaction = 0.91) (<a href="./references#CD007574-fig-0022" title="">Analysis 7.1</a>) (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). </p> <p>There was no difference in participants with good functional outcome between trials that included all planned participants (<a href="./references#CD007574-bbs2-0010" title="BerkhemerOA , FransenPSS , BeumerD , vanden BergLA , LingsmaHF , YooAJ , et al.A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine2015;371:11-20. ">MR CLEAN 2015</a>; <a href="./references#CD007574-bbs2-0011" title="KidwellCS , JanaR , GornbeinJ , AlgerJR , NenovV , AjaniZ , et al.A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine2013;368:914-23. ">MR RESCUE 2013</a>; <a href="./references#CD007574-bbs2-0014" title="FurlanA , HigashidaR , WechslerL , GentM , RowleyH , KaseC , et al.Intra-arterial pro-urokinase for acute ischaemic stroke: the PROACT II study: a randomised controlled trial. JAMA1999;282:2003-11. ">PROACT 2 1999</a>), compared with trials that were stopped early (RR 1.55, 95% CI 1.22 to 1.98 versus RR 1.54, 95% CI 1.39 to 1.70; P for interaction = 0.95) (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>; <a href="./references#CD007574-bbs2-0002" title="LiuX , DaiQ , YeR , ZiW , LiuY , WangH , et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurology2020;19:115-22. ">BEST 2019</a>; <a href="./references#CD007574-bbs2-0003" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine2018;378:11-21. ">DAWN 2018</a>; <a href="./references#CD007574-bbs2-0004" title="AlbersGW , MarksMP , KempS .Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine2018;378:708-18. ">DEFUSE 2018</a>; <a href="./references#CD007574-bbs2-0005" title="KhouryNN , DarsautTE , GhostineJ , DeschaintreY , DaneaultN , DurocherA , et al.Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomised care trial. Journal of Neuroradiology2017;44(3):198-202. ">EASI 2017</a>; <a href="./references#CD007574-bbs2-0006" title="GoyalM , DemchukAM , MenonBK , EesaM , RempelJL , ThorntonJ , et al.Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine2015;372:1019-30. ">ESCAPE 2015</a>; <a href="./references#CD007574-bbs2-0007" title="CampbellBCV , MitchellPJ , KleinigTJ , DeweyHM , ChurilovL , YassiN , et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine2015;372:1009-18. ">EXTEND‐IA 2015</a>; <a href="./references#CD007574-bbs2-0008" title="BroderickJP , PaleshYY , DemchukAM , YeattsSD , KathriP , HillMD , et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine2013;368(10):893-903. ">IMS III 2013</a>; <a href="./references#CD007574-bbs2-0009" title="OgawaA , MoriE , MinematsuK , TakiW , TakahashiA , NemotoS , et al.Randomised trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke. Stroke2007;38:2633-9. ">MELT 2007</a>; <a href="./references#CD007574-bbs2-0012" title="MuirKW , FordGA , Messow C-M, FordI , MurrayA , et al.Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry2017;88:38-44. ">PISTE 2016</a>; <a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>; <a href="./references#CD007574-bbs2-0015" title="MartinsSO , Mont’AlverneF , RebelloLC , AbudDG , SilvaGS , LimaFO , et al.Thrombectomy for stroke in the public health care system of Brazil. New England Journal of Medicine2020;382:2316-26. [ClinicalTrials.gov: NCT02216643]">RESILIENT 2020</a>; <a href="./references#CD007574-bbs2-0016" title="JovinTG , ChamorroA , CoboE , deMiquelMA , MolinaCA , RoviraA , et al.Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine2015;372:2296-306. ">REVASCAT 2015</a>; <a href="./references#CD007574-bbs2-0017" title="SaverJL , GoyalM , BonafeA , Diener H-C, LevyEI , PereiraVM , et al.Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England Journal of Medicine2015;372:2285-95. ">SWIFT PRIME 2015</a>; <a href="./references#CD007574-bbs2-0018" title="MoccoJ , ZaidatOO , vonKummerR , YooAJ , GuptaR , LopesD , et al.Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke2016;47:2331-8. ">THERAPY 2016</a>; <a href="./references#CD007574-bbs2-0019" title="BracardS , DucrocqX , MasJL , SoudantM , OppenheimC , MoulinT , et al.Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurology2016;15:1138-47. ">THRACE 2016</a>). </p> <p>The sensitivity analysis using a random‐effects model (<a href="./references#CD007574-fig-0024" title="">Analysis 7.3</a>) found similar results compared to the fixed‐effect model (<a href="./references#CD007574-fig-0003" title="">Analysis 1.1</a>). The RR was 1.54 (95% CI 1.33 to 1.78) in the random‐effects model compared to RR 1.50 (95% CI 1.37 to 1.63) in the fixed‐effect model. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007574-sec-0081" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007574-sec-0081"></div> <section id="CD007574-sec-0082"> <h3 class="title" id="CD007574-sec-0082">Summary of main results</h3> <p>Since the first version of this review, we have added 15 new studies, bringing the total number of studies to 19, and the total number of participants up from 350 to 3793. With this substantial increase in evidence from randomised controlled trials, it has become clear that endovascular thrombectomy conveys important clinical benefits, with an increase in the chance of a good functional outcome (modified Rankin Scale score 0 to 2), and with no increase in the risk of symptomatic intracranial haemorrhage or death; there was in fact a reduction in the risk of death. The trials were generally of high methodological quality with low to unclear risk of bias, and the results were consistent with very little statistical heterogeneity, meaning that clinicians can be confident that the same results will apply in clinical practice, if similar patients are given similar treatment, in similar acute stroke services. </p> <p>Subgroup analyses showed that the results apply irrespective of whether or not the participants had received intravenous thrombolytic therapy before the intervention, and irrespective of age and sex. Data were insufficient to determine the latest time for treatment to be effective, but subgroup analysis indicated that the results were better in participants with clinically more severe stroke, and in those with more pronounced early ischaemic changes on CT. Our subgroup analysis of four trials with 350 participants showed effect and benefit for functional outcome for intra‐arterial thrombolysis, which adds important information to the ongoing discussion regarding treatment with intra‐arterial thrombolysis for acute ischaemic stroke. </p> </section> <section id="CD007574-sec-0083"> <h3 class="title" id="CD007574-sec-0083">Overall completeness and applicability of evidence</h3> <p>The majority of participants in the included trials had anterior circulation infarcts caused by thrombotic occlusions in a proximal cerebral artery, as verified by CT or MRI angiography, and were treated within eight hours of symptom onset with the stent retriever technique. It is therefore uncertain whether the results can be extrapolated to individuals with posterior circulation infarcts, or to the use of other interventional techniques. Indeed, subgroup analysis showed a significantly lower effect amongst participants treated with techniques other than stent retrievers. We were not able to characterise the acute stroke services in which the participants were treated, so we cannot assess whether the results are limited to a certain organisation of services, or whether they apply irrespective of organisation. </p> </section> <section id="CD007574-sec-0084"> <h3 class="title" id="CD007574-sec-0084">Quality of the evidence</h3> <p>We prepared summary of findings tables using <a href="./references#CD007574-bbs2-0034" title="GRADEpro GDT: GRADEpro Guideline Development Tool [Software].Available from gradepro.org, McMaster University, 2020 (developed by Evidence Prime, Inc.).">GRADE Pro GDT 2020</a> and Cochrane methods. </p> <p>We are confident that the true effect lies close to that of the estimate of the effect.</p> <p>The strengths of this review are that all of the included studies were either at a low or unclear risk of bias. A common source of heterogeneity in systematic reviews is differences in time of follow‐up. All studies in our meta‐analysis, with the exception of <a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>, measured outcome at 90 days' follow‐up. This is therefore a strength of this review. As <a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a> included only 16 participants, we did not explore this in a subgroup analysis. Further, for all endovascular procedures there is a risk that no occlusions are identified for thrombectomy (<a href="./references#CD007574-bbs2-0042" title="NogueiraR , GuptaR , DavalosA .IMS-III and SYNTHESIS expansion trials of endovascular therapy in acute ischaemic stroke. Stroke2013;44:3272-4.">Nogueira 2013</a>). This may attenuate the results and may introduce bias. </p> <p>The weaknesses of this review are that some studies were small, and studies included different types of endovascular treatments, such as either endovascular thrombectomy or intra‐arterial interventions, or a combination of the two. Furthermore, only one trial was double‐blinded (<a href="./references#CD007574-bbs2-0013" title="delZoppoGJ , HigashidaRT , FurlanAJ , PessinMS , RowleyHA , GentM , et al.PROACT: a phase II trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke1998;29:4-11. ">PROACT 1 1998</a>). This trial was of intra‐arterial thrombolysis and did not include mechanical thrombectomy. It is not possible to blind the interventionist when performing mechanical endovascular thrombectomy. Another weakness is that 16 trials were terminated prematurely and therefore lacked statistical power. </p> </section> <section id="CD007574-sec-0085"> <h3 class="title" id="CD007574-sec-0085">Potential biases in the review process</h3> <p>We minimised potential biases in the review process by searching for published and unpublished studies from several sources with no restriction on date of publication or language. Two review authors independently extracted data and conducted risk of bias assessment. </p> </section> <section id="CD007574-sec-0086"> <h3 class="title" id="CD007574-sec-0086">Agreements and disagreements with other studies or reviews</h3> <p>Our review is in line with two recently published systematic reviews of endovascular thrombectomy for acute ischaemic stroke, which showed positive effect of endovascular thrombectomy for acute ischaemic stroke (<a href="./references#CD007574-bbs2-0040" title="LinY , SchultzeV , BrockmeyerM , ParcoC , KarathanosA , HeinenY , et al.Endovascular thrombectomy as a means to improve survival in acute ischemic stroke. A meta-analysis. JAMA Neurology2019;76:850-4.">Lin 2019</a>; <a href="./references#CD007574-bbs2-0047" title="ZhaoZ , ZhangJ , JiangX , WangL , YinZ , HallM , et al.Is endovascular treatment still good for ischemic stroke in real world? A meta-analysis of randomized control trial and observational study in the last decade. Stroke2020;51:3250-63.">Zhao 2020</a>). With its thorough search strategies and identification of more studies than these two meta‐analyses, our review adds to the literature. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007574-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-FIG-01" target="_blank"><b></b></a></p> </div><img alt="PRISMA study flow diagram." data-id="CD007574-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/full#CD007574-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: Favourable functional outcome at end of follow‐up (functional outcome: mRS 0 to 2)." data-id="CD007574-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Funnel plot of comparison: Favourable functional outcome at end of follow‐up (functional outcome: mRS 0 to 2). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/full#CD007574-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Favourable functional outcome at end of follow‐up, Outcome 1: Functional outcome: mRS 0 to 2" data-id="CD007574-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Favourable functional outcome at end of follow‐up, Outcome 1: Functional outcome: mRS 0 to 2 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Favourable functional outcome at end of follow‐up, Outcome 2: Functional outcome: mRS 0 to 1" data-id="CD007574-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Favourable functional outcome at end of follow‐up, Outcome 2: Functional outcome: mRS 0 to 1 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Death from all causes, Outcome 1: Death from all causes at end of follow‐up" data-id="CD007574-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Death from all causes, Outcome 1: Death from all causes at end of follow‐up</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Death from all causes, Outcome 2: Death from all causes within acute phase (first 2 weeks)" data-id="CD007574-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Death from all causes, Outcome 2: Death from all causes within acute phase (first 2 weeks) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Symptomatic intracranial haemorrhage (NINDS), Outcome 1: Symptomatic intracranial haemorrhage within 24 hours" data-id="CD007574-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Symptomatic intracranial haemorrhage (NINDS), Outcome 1: Symptomatic intracranial haemorrhage within 24 hours </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Symptomatic intracranial haemorrhage (NINDS), Outcome 2: Symptomatic intracranial haemorrhage at the end of follow‐up" data-id="CD007574-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Symptomatic intracranial haemorrhage (NINDS), Outcome 2: Symptomatic intracranial haemorrhage at the end of follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Neurological outcome at the end of follow‐up, Outcome 1: Neurological outcome: NIHSS 0 to 1" data-id="CD007574-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Neurological outcome at the end of follow‐up, Outcome 1: Neurological outcome: NIHSS 0 to 1 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Degree of recanalisation, Outcome 1: Recanalisation: TIMI grade 3" data-id="CD007574-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Degree of recanalisation, Outcome 1: Recanalisation: TIMI grade 3</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Degree of recanalisation, Outcome 2: Recanalisation: TICI grade 2 and 3" data-id="CD007574-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Degree of recanalisation, Outcome 2: Recanalisation: TICI grade 2 and 3 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Subgroup analyses (functional outcome), Outcome 1: Age" data-id="CD007574-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Subgroup analyses (functional outcome), Outcome 1: Age</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Subgroup analyses (functional outcome), Outcome 2: Sex" data-id="CD007574-fig-0013" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Subgroup analyses (functional outcome), Outcome 2: Sex</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-006.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Subgroup analyses (functional outcome), Outcome 3: Stroke severity (NIHSS score)" data-id="CD007574-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-006.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: Subgroup analyses (functional outcome), Outcome 3: Stroke severity (NIHSS score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-006.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Subgroup analyses (functional outcome), Outcome 4: Early ischaemic changes on CT according to the Alberta Stroke Program Early CT Score (ASPECTS)" data-id="CD007574-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-006.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6: Subgroup analyses (functional outcome), Outcome 4: Early ischaemic changes on CT according to the Alberta Stroke Program Early CT Score (ASPECTS) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-006.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Subgroup analyses (functional outcome), Outcome 5: Mean time to groin puncture or initiation of intra‐arterial treatment" data-id="CD007574-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-006.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6: Subgroup analyses (functional outcome), Outcome 5: Mean time to groin puncture or initiation of intra‐arterial treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-006.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Subgroup analyses (functional outcome), Outcome 6: Intravenous thrombolytic medication" data-id="CD007574-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-006.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6: Subgroup analyses (functional outcome), Outcome 6: Intravenous thrombolytic medication </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-006.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Subgroup analyses (functional outcome), Outcome 7: Types of endovascular treatments" data-id="CD007574-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-006.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6: Subgroup analyses (functional outcome), Outcome 7: Types of endovascular treatments </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-006.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Subgroup analyses (functional outcome), Outcome 8: Localisation of cerebral artery occlusion" data-id="CD007574-fig-0019" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-006.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6: Subgroup analyses (functional outcome), Outcome 8: Localisation of cerebral artery occlusion </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-006.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Subgroup analyses (functional outcome), Outcome 9: Location of occlusion" data-id="CD007574-fig-0020" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-006.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6: Subgroup analyses (functional outcome), Outcome 9: Location of occlusion</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-006.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Subgroup analyses (functional outcome), Outcome 10: Penumbra imaging in selecting patients to treatment" data-id="CD007574-fig-0021" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-006.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.10</div> <div class="figure-caption"> <p>Comparison 6: Subgroup analyses (functional outcome), Outcome 10: Penumbra imaging in selecting patients to treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-006.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Sensitivity analyses (functional outcome, mRS 0 to 2, or mRS 0 to 1 if data not available for mRS 0 to 2)), Outcome 1: Trials included in the previous review vs trials included in the current review" data-id="CD007574-fig-0022" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Sensitivity analyses (functional outcome, mRS 0 to 2, or mRS 0 to 1 if data not available for mRS 0 to 2)), Outcome 1: Trials included in the previous review vs trials included in the current review </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Sensitivity analyses (functional outcome, mRS 0 to 2, or mRS 0 to 1 if data not available for mRS 0 to 2)), Outcome 2: Trials that included all planned participants vs trials stopped early" data-id="CD007574-fig-0023" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: Sensitivity analyses (functional outcome, mRS 0 to 2, or mRS 0 to 1 if data not available for mRS 0 to 2)), Outcome 2: Trials that included all planned participants vs trials stopped early </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007574-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/urn:x-wiley:14651858:media:CD007574:CD007574-CMP-007.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Sensitivity analyses (functional outcome, mRS 0 to 2, or mRS 0 to 1 if data not available for mRS 0 to 2)), Outcome 3: Functional outcome: mRS 0 to 2 (random effects)" data-id="CD007574-fig-0024" src="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-007.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_t/tCD007574-CMP-007.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7: Sensitivity analyses (functional outcome, mRS 0 to 2, or mRS 0 to 1 if data not available for mRS 0 to 2)), Outcome 3: Functional outcome: mRS 0 to 2 (random effects) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/media/CDSR/CD007574/image_n/nCD007574-CMP-007.03.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007574-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Endovascular thrombectomy interventions compared to standard therapy for acute ischaemic stroke</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Endovascular thrombectomy interventions compared to standard therapy for acute ischaemic stroke</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute ischaemic stroke<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> endovascular thrombectomy or intra‐arterial interventions, or both<br/><b>Comparison:</b> standard therapy </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with routine medical treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with endovascular thrombectomy interventions</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favourable functional outcome at the end of follow‐up (primary outcome: mRS score 0 to 2) </p> <p>Follow‐up: 90 days<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>290 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>435 per 1000<br/>(397 to 475) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.50<br/>(1.37 to 1.63) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3715<br/>(18 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death from all causes at the end of follow‐up</p> <p>Follow‐up: 90 days<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>207 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>176 per 1000<br/>(153 to 203) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.85<br/>(0.75 to 0.97) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3793<br/>(19 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptomatic intracranial haemorrhage at the</p> <p>end of follow‐up (NINDS)</p> <p>Follow‐up: 90 days<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>58 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>58 per 1000<br/>(37 to 88) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.05<br/>(0.72 to 1.52) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1752<br/>(10 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neurological status at the end of follow‐up (NIHSS)</p> <p>Follow‐up: 90 days<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>123 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>250 per 1000<br/>(149 to 418) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.03<br/>(1.21 to 3.40) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>334<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Degree of recanalisation (TIMI grade)</p> <p>Follow‐up: End of endovascular procedure</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>129 per 1000<br/>(25 to 655) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 8.25<br/>(1.63 to 41.90) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>198<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>mRS: </b> modified Rankin Scale; <b>NINDS: </b> National Institute of Neurological Disorders and Stroke; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>All trials had 90 days follow‐up with the exception of one trial of 16 patients (<a href="./references#CD007574-bbs2-0001" title="MacleodM , DavisS , MitchellP , GerratyRP , FittG , HankeyGJ , et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovascular Diseases2005;20:12-7. ">AUST 2005</a>). </p> <p><sup>b</sup>Only one of these RCTs could be blinded for surgeons or participants due to the nature of the intervention. </p> <p><sup>c</sup>Downgraded for imprecision (wide confidence interval) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Endovascular thrombectomy interventions compared to standard therapy for acute ischaemic stroke</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/full#CD007574-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007574-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Favourable functional outcome at end of follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Functional outcome: mRS 0 to 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3715</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [1.37, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Functional outcome: mRS 0 to 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [1.42, 1.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Favourable functional outcome at end of follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007574-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Death from all causes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Death from all causes at end of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3793</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.75, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Death from all causes within acute phase (first 2 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1243</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.77, 1.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Death from all causes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007574-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Symptomatic intracranial haemorrhage (NINDS)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Symptomatic intracranial haemorrhage within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.91, 2.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Symptomatic intracranial haemorrhage at the end of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1752</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.72, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Symptomatic intracranial haemorrhage (NINDS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007574-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Neurological outcome at the end of follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Neurological outcome: NIHSS 0 to 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>334</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.03 [1.21, 3.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Neurological outcome at the end of follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007574-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Degree of recanalisation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Recanalisation: TIMI grade 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.25 [1.63, 41.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Recanalisation: TICI grade 2 and 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.11 [2.18, 4.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Degree of recanalisation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007574-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Subgroup analyses (functional outcome)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.1 Younger age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [1.48, 2.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.2 Older age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [1.18, 1.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Sex <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.1 Men</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [1.37, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.2 Women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [1.34, 1.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 Stroke severity (NIHSS score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.1 Lower NIHSS score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [1.22, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.2 Higher NIHSS score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [1.57, 2.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.4 Early ischaemic changes on CT according to the Alberta Stroke Program Early CT Score (ASPECTS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.1 Lower ASPECT score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.01 [1.53, 2.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.2 Higher ASPECT score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [1.19, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.5 Mean time to groin puncture or initiation of intra‐arterial treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.1 Shorter (&lt; 250 minutes)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>686</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [1.40, 2.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.2 Medium (250 to 300 minutes)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1335</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [1.11, 1.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.3 Longer (&gt; 300 minutes)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.97, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.6 Intravenous thrombolytic medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.1 Given</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.95 [1.55, 2.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.2 Not given</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.18 [1.37, 3.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.7 Types of endovascular treatments <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7.1 Trials with participants treated with intra‐arterial treatment alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [1.08, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7.2 Trials with a majority of participants treated with first‐generation mechanical devices </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>747</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.87, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7.3 Trials with a majority of participants treated with stent retrievers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.80 [1.59, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.8 Localisation of cerebral artery occlusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.8.1 Trials that included both proximal and non‐proximal strokes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1097</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.99, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.8.2 Trials of that only included proximal occlusion strokes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.71 [1.47, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.9 Location of occlusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.9.1 Internal carotid artery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.61 [1.88, 3.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.9.2 M1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [1.33, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.9.3 M2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.41, 4.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.10 Penumbra imaging in selecting patients to treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.10.1 Used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>379</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [1.22, 2.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.10.2 Not used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [1.25, 1.59]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Subgroup analyses (functional outcome)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007574-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Sensitivity analyses (functional outcome, mRS 0 to 2, or mRS 0 to 1 if data not available for mRS 0 to 2))</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Trials included in the previous review vs trials included in the current review <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [1.37, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.1 Trials included in the previous review</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [1.08, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.2 Trials included in the current review</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3755</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [1.37, 1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 Trials that included all planned participants vs trials stopped early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3533</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [1.40, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2.1 Trials that included all planned participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>798</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [1.22, 1.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2.2 Trials stopped early</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2735</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [1.39, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.3 Functional outcome: mRS 0 to 2 (random effects) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3715</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [1.33, 1.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Sensitivity analyses (functional outcome, mRS 0 to 2, or mRS 0 to 1 if data not available for mRS 0 to 2))</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007574.pub3/references#CD007574-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007574.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD007574-note-0023">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007574-note-0019">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007574-note-0021">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD007574-note-0017">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD007574-note-0015">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD007574-note-0011">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD007574-note-0013">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD007574-note-0007">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD007574-note-0009">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007574\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007574\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007574\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007574\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007574\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007574.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007574.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007574.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007574.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007574.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726518283"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007574.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726518286"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007574.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e959c2b58f3c9',t:'MTc0MDcyNjUxOC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 